FindTrial
Sign In

Intracoronary vs Intravenous of Full Loading dose Bivalirudin Followed by Standard Intravenous Infusion in PPCI of STEMI: A prospective, Randomized, Contronelled Trial

Intracoronary vs Intravenous of Full Loading dose Bivalirudin Followed by Standard Intravenous Infusion in PPCI of STEMI

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800017280
Enrollment
Unknown
Registered
2018-07-20
Start date
2018-07-20
Completion date
Unknown
Last updated
2018-07-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

STEMI

Interventions

Intracoronary Bivalirudin Group:Intracoronary loading dose of Bivalirudin
Intravenous Bivalirudin Group:Intravenous loading dose of Bivalirudin

Sponsors

Guangzhou Red Cross Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 120 Years

Inclusion criteria

Inclusion criteria: STEMI patients planned for PPCI

Exclusion criteria

Exclusion criteria: active hemorrhage

Design outcomes

Primary

MeasureTime frame
efficacy and safety;—

Countries

China

Contacts

Public ContactLi Li

Guangzhou Red Cross Hospital

lilygs@126.com+86 18928900300

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026